Transforming growth factor-β1 regulates the fate of cultured spinal cord-derived neural progenitor cells

Cell Proliferation

Volumn 41, Issue 2, 2008, Pages 248-264

  Park, S M ^a   Jung, J S ^a   Jang, M S ^b   Kang, K S ^b   Kang, S K ^a  

^a Pusan National University School of Medicine   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; CASPASE 3; CASPASE 9; CYTOCHROME C; HYDROGEN PEROXIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; RNA; SMAD2 PROTEIN; SMALL INTERFERING RNA; THIOREDOXIN REDUCTASE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL CULTURE; CELL DIFFERENTIATION; CELL FATE; CELL GROWTH; CELL ISOLATION; CELL MIGRATION; CELL POPULATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; ENZYME INACTIVATION; FEMALE; NONHUMAN; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; SPINAL CORD; STEM CELL;

ANIMALS; BCL-2-ASSOCIATED X PROTEIN; BENZAMIDES; CELL DEATH; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CYTOCHROMES C; DIOXOLES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HYDROGEN PEROXIDE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEURONS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, WISTAR; RNA, SMALL INTERFERING; SPINAL CORD; STEM CELLS; THIOREDOXIN REDUCTASE 1; TRANSFORMING GROWTH FACTOR BETA1;

EID: 40549098704     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/j.1365-2184.2008.00514.x     Document Type: Article

References (41)

1. Armstrond RC, Aja TJ, Hoand KD (1997) Activation of the CED3/ICE-related protease-CPP32 in cerebellar granule neurons undergoing apoptosis but not necrosis. J. Neurosci. 17, 553 562.
2. Attisano L, Carcamo J, Ventura F, Weis FM, Massague J, Wrana JL (1993) Identification of human activin and TGF beta type I receptors that form heteromeric kinase complexes with type II receptors. Cell 75, 671 680.
3. Bakin AV, Tomlinson AK, Bhowmick NA, Moses HL, Arteaga CL (2000) Phosphatidylinositol 3-kinase function is required for transforming growth factor β-mediated epithelial to mesenchymal transition and cell migration. J. Biol. Chem. 275, 36803 36810.
4. Bakin AV, Rinehart C, Tomlinson AK, Arteaga CL (2002) p38 mitogen-activated protein kinase is required for TGF-β-mediated fibroblastic transdifferentiation and cell migration. J. Cell Sci. 115, 3193 3206.
5. Bhowmick NA, Ghiassi M, Bakin A (2001) Transforming growth factor β1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol. Biol. Cell 12, 27 36.
6. Buisson A, Nicole O, Docagne F, Sartelet H, Mackenzie ET, Vivien D (1998) Up-regulation of a serine protease inhibitor in astrocytes mediates the neuroprotective activity of transforming growth factor β1. FASEB J. 12, 1683 1691.
7. Burkle A (2001) Physiology and pathophysiology of poly (ADP-ribosyl)ation. BioEssays 23, 795 806.
8. Derynck R, Zhang YE (2003) Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425, 577 584.
9. Docagne F, Nicole O, Gabriel C, Fernandez-Monreal M, Lesne S, Ali C, Plawinski L, Carmeliet P, MacKenzie ET, Buisson A, Vivien D (2002) Smad3-dependent induction of PAl-1 in astrocytes mediates neuroprotective activity of TGF-β1 against NMDA-induced necrosis. Mol. Cell. Neurosci. 21, 634 644.
10. Feng XH, Derynck R (2005) Specificity and versatihity in TGF-β signaling through Smads. Annu. Rev. Cell Dev. Biol. 21, 659 693.
11. Flanders KC, Ren RF, Lippa CF (1998) Transforming growth factor betas in neurodegenerative diseases. Prog. Neurobiol. 54, 71 85.
12. Gangemi RM, perera M, Corte G (2004) Regulatory genes controlling cell fate choice in embryonic and adult neural stem cells. J. Neurochem. 89, 286 306.
13. Gross CE, Bednar MM, Howard DB, Sporn MB (1993) Transforming growth factor-beta I reduces infarct size after experimental cerebral ischemia in a rabbit model. Stroke 24, 558 562.
14. Heldin CH, Miyazono K, ten Dijke P (1997) TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 390, 465 471.
15. Henrich-Noack P, Prehn JH, Krieglstein J (1996) TGF-beta 1 protects hippocampal neurons against degeneration caused by transient global ischemia. Dose-response relationship and potential neuroprotective mechanisms. Stroke 27, 1609 1614.
16. Kang SK, So HW, Moon YS, Kim CH (2006) Proteomic analysis of injured spinal cord tissue protein using 2 D-E and MALDI-TOF Mass. Proteomics 6, 2797 2812.
17. Krieglstein K, Strelau J, Shober A, Sullivan A, Unsicker K (2002) TGF-β and the regulation of neuron survival and death. J. Physiol. (Paris) 96, 25 30.
18. Kyriakis JM, Avruch J (2001) Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 81, 807 886.
19. Lagna G, Hata A, Hemmati-Brivanlou A, Massague J (1996) Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways. Nature 383, 832 836.
20. LaPlaca MC, Zhang J, Raghupathi R (2001) Pharmacologic inhibition of poly (ADP-b ribose) polymerase is neuroprotective following traumatic brain injury in rats. J. Neurotrauma 18, 369 376.
21. Letterio JJ, Roberts AB (1998) Regulation of immune responses by TGF-β. Annu. Rev. Immunol. 16, 137 161.
22. Liu D, Ling X, Wen J, Liu J (2000) The role of reactive nitrogen species in secondary spinal cord injury: formation of nitric oxide, peroxynitrite, and nitrated protein. J. Neurochem. 75, 2144 2154.
23. Massague J (2003) Integration of Smad and MAPK pathways: a link and a linker revisited. Genes Dev. 17, 2993 2997.
24. Massague J, Wotton D (2000) Transcriptional control by the TGF-beta/Smad signaling system. EMBO J. 19, 1745 1754.
25. Mattson MP, Barger SW, Furnkawa K, Bruce AJ, Wyss-Coray T, Mark RJ, Mucke L (1997) Cellular signalling role of TGF-β, TNFalpha and beta APP in brain injury responses and Alzheimer's disease. Brain Res. Rev. 23, 47 61.
26. McNeill H, Williams C, Guan J, Dragunow M, Lawlor P, Sirimanne E, Nikolics K, Gluckman P (1994) Neuronal rescue with transforming growth factor-beta 1 after hypoxic-ischaemic brain injury. NeuroReport 5, 901 904.
27. Pang L, Wen Y, Che XM, Roessler BJ, Betz AL, Yang GY (2001) Reduction of inflammatory response in the mouse brain with adenoviral-mediated transforming growth factor-β1 expression. Stroke 32, 544 552.
28. Prehn JHM, Bindokas VP, Jordan J, Galindo MF, Ghadge GD, Roos FP, Bosie LH, Tompson CB, Krajewski S, Reed JC, Miller RJ (1996) Protective effect of transforming growth factor-β1 on β-amyloid neurotoxicity in rat hippocampal neurons. Mol. Pharmacol. 49, 319 328.
29. Prehn JHM, Bindokas VP, Marcuccilli CJ, Krajewski D, Reed JC, Miller RJ (1994) Regulation of neuronal Bcl-2 protein expression and calcium homeostasis by transforming growth factor beta confers wide-ranging protection on rat hippocampal neurons. Proc. Natl. Acad. Sci. USA 91, 12599 12603.
30. Ren RF, Flanders KC (1996) Transforming growth factor-β protects primary rat hippocampal neuronal cultures from degeneration induced by β-amyloid peptide. Brain Res. 732, 16 24.
31. Roux PP, Blenis J (2004) ERK and p38 MAPK-activated protein kinases with diverse biological function. Microbiol. Mol. Biol. Rev. 68, 320 344.
32. Ruocco A, Nicole O, Docagne F, Ali C, Chazalviel L, Komesli S, Yablonsky F, Roussel S, MacKenzie ET, Vivien D, Buisson A (1999) A transforming growth factor-beta antagonist unmasks the ischemic brain injury. J. Cereb. Blood Flow Metab. 19, 1345 1353.
33. Scott GS, Jakeman LB, Stokes BT, Szabo C (1999) Peroxynitrite production and activation of poly (adenosine diphosphate-ribose) synthetase in spinal cord injury. Ann. Neurol. 45, 120 124.
34. Skaper SD (2003) Poly (ADP-Ribose) polymerase-1 in acute neuronal death and inflammation: a strategy for neuroprotection. Ann. N.Y. Acad. Sci. 993, 217 228.
35. Tang Y, Katuri V, Dillner A, Mishra B, Deng CX, Mishra L (2003) Disruption of transforming growth factor-β signaling in ELF β-spectrin-deficient mice. Science 24, 574 577.
36. Ten Dijke P, Hill CS (2004) New insights into TGF-β SMAD signaling. Trend Biochem. Sci. 29, 265 273.
37. Tikka T, Fiebich BL, Goldsteins G, Keinanen R, Koistinaho J (2001) Minocycline a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J. Neurosci. 21, 2580 2588.
38. Wakefield LM, Roberts AB (2002) TGF-β signaling: positive and negative effects on tumorigenesis. Curr. Opin. Genet. Dev. 12, 22 29.
39. Wrana JL, Attisano L, Carcamo J, Zentella A, Doody J, Laiho M, Wang XF, Massague J (1992) TGF beta signals through a heteromeric protein kinase receptor complex. Cell 71, 1003 1014.
40. Wyss-Coray T, Feng L, Masliah E, Ruppe MD, Lee HS, Toggas SM, Rockenstein EM, Mucke L (1995) Increased central nervous system production of extracellular matrix components and development of hydrocephalus in transgenic mice overexpressing transforming growth factor-beta 1. Am. J. Pathol. 147, 53 67.
41. Yrjanheikki J, Keinanen R, Pellikka M, Hokfelt T, Koistinaho J (1998) Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc. Natl. Acad. Sci. USA 95, 15769 15774.